An endolysin Salmcide-p1 from bacteriophage fmb-p1 against gram-negative bacteria

J Appl Microbiol. 2022 Sep;133(3):1597-1609. doi: 10.1111/jam.15661. Epub 2022 Jun 27.

Abstract

Aims: A novel endolysin Salmcide-p1 was developed as a promising candidate of new preservative and a supplement to effective enzyme preparations against gram-negative bacterial contaminations.

Methods and results: Salmcide-p1 was identified by complementing the genomic sequence of a virulent Salmonella phage fmb-p1. Salmcide-p1 of 112 μg ml-1 could quickly kill Salmonella incubated with 100 mmol l-1 EDTA, with no haemolytic activity. Meanwhile, Salmcide-p1 had a high activity of lysing Salmonella cell wall peptidoglycan. At different temperatures (4-75°C), pH (4-11) and NaCl concentration (10-200 mmol l-1 ), the relative activity of Salmcide-p1 was above 60%. At 4°C, the combination of Salmcide-p1 and EDTA-2Na could inhibit the number of Salmonella Typhimurium CMCC 50115 in skim milk to less than 4 log CFU ml-1 by 3 days, and the number of Shigella flexneri CMCC 51571 was lower than 4 log CFU ml-1 by 9 days.

Conclusions: Salmcide-p1 had a wide bactericidal activity against gram-negative bacteria and showed a broader anti-Salmonella spectrum than the phage fmb-p1. The combination strategy of Salmcide-p1 and EDTA-2Na could significantly inhibit the growth of gram-negative bacteria inoculated in skim milk.

Significance and impact of the study: Bacteriophage endolysin as an antibacterial agent is considered to be a new strategy against bacterial contamination.

Keywords: bactericidal spectrum; endolysin; peptidoglycan; skim milk; virulent salmonella phage.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteriophage P1*
  • Bacteriophages* / genetics
  • Edetic Acid / pharmacology
  • Endopeptidases / genetics
  • Endopeptidases / pharmacology
  • Gram-Negative Bacteria
  • Salmonella typhimurium / genetics

Substances

  • Anti-Bacterial Agents
  • Edetic Acid
  • Endopeptidases
  • endolysin